Kevin Roggin, M.D. Joins MUSC; Named Division Chief of Surgical Oncology

The MUSC Department of Surgery is excited to announce that Kevin Roggin, M.D., has been named the new Chief of Surgical Oncology, effective September 1, 2023. Dr. Roggin is a distinguished surgical oncologist, scholar, and educator, having served at the University of Chicago Medicine Center (UCMC) for the past 17 years.  He began his career at UCMC as an Assistant Professor of Surgery in 2005, following the completion of a fellowship in surgical oncology at the Memorial Sloan Kettering Cancer Center. While at UCMC, Dr. Roggin rose to the rank of Professor of Surgery and Cancer

At MUSC, Dr. Roggin will enhance the division’s clinical programs, creating collaborative, multidisciplinary approaches to liver, pancreas, and biliary disease and expanding the HIPEC, endocrine, and breast programs. He will also serve as Clinical Director for Surgical Oncology at the Hollings Cancer Center, working closely with the Hollings ICCE leadership to grow these key clinical areas. 

A nationally recognized leader in surgical oncology, Dr. Roggin has served two three-year terms on the Executive Council of the Society of Surgical Oncology (SSO) and as Chair of the SSO Training Committee, where he helped shepherd the transition of the SSO training programs to an ACGME-approved Complex General Surgical Oncology fellowship.

An innovator and expert in robotic surgery, Dr. Roggin was instrumental in introducing robotic approaches to many complex surgical oncology procedures at UCMC. He is the first surgeon at UCMC to perform a robotic Whipple procedure, a robotic distal pancreatectomy, a robotic hepatectomy, and a total robotic gastrectomy.  He helped develop a robust multidisciplinary program for the management of CDH1 gene mutations carriers using virtual visits and has performed over 25 minimally invasive operations for patients needing a risk-reducing total gastrectomy over the last four years. A board-certified general surgeon and surgical oncologist, he specializes in the surgical treatment of complex upper gastrointestinal tract and hepato-pancreato-biliary (HPB) cancers (including stomach, pancreas, liver, gallbladder, and extrahepatic bile duct cancers, retroperitoneal sarcomas, and gastrointestinal stromal tumors (GIST)). 

Since 2011, Dr. Roggin has been the UCMC General Surgery program director and mentored countless medical students and trainees. In this role, he is credited with creating a culture of belonging and respect, fostering diversity and inclusion in the residency programs. In 2019, he was honored with the inaugural University of Chicago Medicine Program Director of the Year Award. He is a Master Educator in the Academy of Medical Educators at the Pritzker School of Medicine, which is an honor bestowed upon faculty members who have demonstrated significant contributions to medical education at the University of Chicago.  

The Department of Surgery is extremely grateful to our current Division Chief David Mahvi, M.D., for his many years of leadership and significant contributions to the growth and expansion of clinical expertise in the division, providing a solid foundation for Dr. Roggin’s new leadership role.